Leukemia specific loss of heterozygosity of MHC in a CLL patient: Disease state impacts timing of confirmatory typing

Human Immunology

Volumn 74, Issue 1, 2013, Pages 41-44

  Coppage, Myra ^a   Iqbal, Anwar ^a   Ahmad, Ausaf ^a   Becker, Michael W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; FLUDARABINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB;

ADULT; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; BACTEREMIA; CASE REPORT; CELL TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CRYOPRESERVATION; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; FEVER; GENE LOCUS; GENOTYPE; GRANULOCYTE TRANSFUSION; HAPLOTYPE; HETEROZYGOSITY LOSS; HLA TYPING; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LYMPHADENOPATHY; MALE; MICROARRAY ANALYSIS; PANCYTOPENIA; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; TIME FACTORS; TRANSPLANTATION CONDITIONING; UNRELATED DONORS; VIDARABINE;

EID: 84870903722     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.003     Document Type: Article

References (17)

1. Gunnarsson R., Mansouri L., Isaksson A., Goransson H., Cahill N., Jansson M., et al. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica 2011, 96:1161.
2. Pfeifer D., Pantic M., Skatulla I., Rawluk J., Kreutz C., Martens U.M., et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 2007, 109:1202.
3. Afable M.G., Wlodarski M., Makishima H., Shaik M., Sekeres M.A., Tiu R.V., et al. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood 2011, 117:6876.
4. Dubois V., Sloan-Bena F., Cesbron A., Hepkema B.G., Gagne K., Gimelli S., et al. Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy. Leukemia 2012, 26(9):2079.
5. McEvoy C.R., Morley A.A., Firgaira F.A. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2003, 37:321.
6. Gartenhaus R.B. Microsatellite instability in hematologic malignancies. Leuk Lymphoma 1997, 25:455.
7. Bodmer W.F., Browning M.J., Krausa P., Rowan A., Bicknell D.C., Bodmer J.G. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann NY Acad Sci 1993, 690:42.
8. Park H., Hyun J., Park S.S., Park M.H., Song E.Y. False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia. Korean J Lab Med 2011, 31:302.
9. Schneider BA HL, Chambers NL, Kroning C, Gandhi MJ. Cost effective streamlined implementation of the 2009 ASHI mandated bone marrow and stem cell transplantation confirmatory HLA typing standard. The American Society for Histocompatibility and Immunogenetics, 36th Annual Meeting, vol. 71, S1. HollyWood, Florida: Human Immunology; 2010. p. S127.
10. Smith A.G., Fan W., Regen L., Warnock S., Sprague M., Williams R., et al. Somatic mutations in the HLA genes of patients with hematological malignancy. Tissue Antigens 2012, 79:359.
11. Pereira S., Vayntrub T., Hiraki D.D., Cherry A.M., Arai S., Dvorak C.C., et al. Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants. Hum Immunol 2011, 72:503.
12. Vago L., Perna S.K., Zanussi M., Mazzi B., Barlassina C., Stanghellini M.T.L., et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 2009, 361:478.
13. Villalobos I.B., Takahashi Y., Akatsuka Y., Muramatsu H., Nishio N., Hama A., et al. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. Blood 2010, 115:3158.
14. van Luijn M.M., Chamuleau M.E., Ossenkoppele G.J., van de Loosdrecht A.A., Marieke van Ham S. Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation. Oncoimmunology 2012, 1:211.
15. Maki G., Hayes G.M., Naji A., Tyler T., Carosella E.D., Rouas-Freiss N., et al. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia 2008, 22:998.
16. Nuckel H., Switala M., Sellmann L., Horn P.A., Durig J., Duhrsen U. The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia 2010, 24:1152.
17. Gonzalez-Rodriguez A.P., Contesti J., Huergo-Zapico L., Lopez-Soto A., Fernandez-Guizan A., Acebes-Huerta A., et al. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia. Leuk Lymphoma 2010, 51:1829.